Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection
J. Piret et al., Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection, ANTIM AG CH, 44(1), 2000, pp. 30-38
The topical efficacies of foscarnet and acyclovir incorporated into a polyo
xypropylene-polyoxyethylene polymer were evaluated and compared to that of
5% acyclovir ointment (Zovirax) by use of a murine model of cutaneous herpe
s simplex virus type 1 infection. All three treatments given three times da
ily for 4 days and initiated 24 h after infection prevented the development
of the zosteriform rash in mice. The acyclovir formulation and the acyclov
ir ointment reduced the virus titers below detectable levels in skin sample
s from the majority of mite, whereas the foscarnet formulation has less of
an antiviral effect. Reducing the number of treatments to a single applicat
ion given 24 h postinfection resulted in a significantly higher efficacy of
the formulation of acyclovir than of the acyclovir ointment. Acyclovir inc
orporated within the polymer was also significantly more effective than the
acyclovir ointment when treatment was initiated on day 5 postinfection. Th
e higher efficacy of the acyclovir formulation than of the acyclovir ointme
nt is attributed to the semiviscous character of the polymer, which allows
better penetration of the drug into the skin.